Cargando…
SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV
The serine incorporator 5 (SERINC5) is a recently discovered restriction factor that inhibits viral infectivity by preventing fusion. Retroviruses have developed strategies to counteract the action of SERINC5, such as the expression of proteins like negative regulatory factor (Nef), S2, and glycosyl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735641/ https://www.ncbi.nlm.nih.gov/pubmed/29359168 http://dx.doi.org/10.1155/2017/1548905 |
_version_ | 1783287250517229568 |
---|---|
author | Gonzalez-Enriquez, Gracia Viviana Escoto-Delgadillo, Martha Vazquez-Valls, Eduardo Torres-Mendoza, Blanca Miriam |
author_facet | Gonzalez-Enriquez, Gracia Viviana Escoto-Delgadillo, Martha Vazquez-Valls, Eduardo Torres-Mendoza, Blanca Miriam |
author_sort | Gonzalez-Enriquez, Gracia Viviana |
collection | PubMed |
description | The serine incorporator 5 (SERINC5) is a recently discovered restriction factor that inhibits viral infectivity by preventing fusion. Retroviruses have developed strategies to counteract the action of SERINC5, such as the expression of proteins like negative regulatory factor (Nef), S2, and glycosylated Gag (glycoGag). These accessory proteins downregulate SERINC5 from the plasma membrane for subsequent degradation in the lysosomes. The observed variability in the action of SERINC5 suggests the participation of other elements like the envelope glycoprotein (Env) that modulates susceptibility of the virus towards SERINC5. The exact mechanism by which SERINC5 inhibits viral fusion has not yet been determined, although it has been proposed that it increases the sensitivity of the Env by exposing regions which are recognized by neutralizing antibodies. More studies are needed to understand the role of SERINC5 and to assess its utility as a therapeutic strategy. |
format | Online Article Text |
id | pubmed-5735641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-57356412018-01-22 SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV Gonzalez-Enriquez, Gracia Viviana Escoto-Delgadillo, Martha Vazquez-Valls, Eduardo Torres-Mendoza, Blanca Miriam J Immunol Res Review Article The serine incorporator 5 (SERINC5) is a recently discovered restriction factor that inhibits viral infectivity by preventing fusion. Retroviruses have developed strategies to counteract the action of SERINC5, such as the expression of proteins like negative regulatory factor (Nef), S2, and glycosylated Gag (glycoGag). These accessory proteins downregulate SERINC5 from the plasma membrane for subsequent degradation in the lysosomes. The observed variability in the action of SERINC5 suggests the participation of other elements like the envelope glycoprotein (Env) that modulates susceptibility of the virus towards SERINC5. The exact mechanism by which SERINC5 inhibits viral fusion has not yet been determined, although it has been proposed that it increases the sensitivity of the Env by exposing regions which are recognized by neutralizing antibodies. More studies are needed to understand the role of SERINC5 and to assess its utility as a therapeutic strategy. Hindawi 2017 2017-11-22 /pmc/articles/PMC5735641/ /pubmed/29359168 http://dx.doi.org/10.1155/2017/1548905 Text en Copyright © 2017 Gracia Viviana Gonzalez-Enriquez et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Gonzalez-Enriquez, Gracia Viviana Escoto-Delgadillo, Martha Vazquez-Valls, Eduardo Torres-Mendoza, Blanca Miriam SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV |
title | SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV |
title_full | SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV |
title_fullStr | SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV |
title_full_unstemmed | SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV |
title_short | SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV |
title_sort | serinc as a restriction factor to inhibit viral infectivity and the interaction with hiv |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735641/ https://www.ncbi.nlm.nih.gov/pubmed/29359168 http://dx.doi.org/10.1155/2017/1548905 |
work_keys_str_mv | AT gonzalezenriquezgraciaviviana serincasarestrictionfactortoinhibitviralinfectivityandtheinteractionwithhiv AT escotodelgadillomartha serincasarestrictionfactortoinhibitviralinfectivityandtheinteractionwithhiv AT vazquezvallseduardo serincasarestrictionfactortoinhibitviralinfectivityandtheinteractionwithhiv AT torresmendozablancamiriam serincasarestrictionfactortoinhibitviralinfectivityandtheinteractionwithhiv |